Literature DB >> 2903769

Interaction of electrically charged drug molecules with phospholipid membranes.

D Barthel1, O Zschoernig, K Lange, R Lenk, K Arnold.   

Abstract

Model membranes (egg-yolk PC liposomes) were exposed to the cationic form of amphiphilic drugs. Microelectrophoresis was used to measure the change of the electrokinetic potential as a function of the drug concentration. By use of the Gouy-Chapman theory the surface potential and surface charge density were calculated. A theoretical model postulating a simple partition equilibrium of the charged drug molecules between the membrane and the aqueous phase in the vicinity of the membrane failed to describe the experimental results. Modification of the partition law by introducing a mechanism of saturation at high drug concentrations, however, resulted in concordance of model and experiment. Some parameters of the model can be used as a means of evaluating the efficiency of neuroactive drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903769     DOI: 10.1016/0005-2736(88)90498-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Characteristics of the binding of tacrine to acidic phospholipids.

Authors:  J Y Lehtonen; M Rytömaa; P K Kinnunen
Journal:  Biophys J       Date:  1996-05       Impact factor: 4.033

2.  Relative surface charge density mapping with the atomic force microscope.

Authors:  W F Heinz; J H Hoh
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

3.  Interaction of chlorpromazine with phospholipid membranes. An EPR study of membrane surface potential effects.

Authors:  C Anteneodo; P M Bisch; J F Marques
Journal:  Eur Biophys J       Date:  1995       Impact factor: 1.733

4.  Partitioning of Catechol Derivatives in Lipid Membranes: Implications for Substrate Specificity to Catechol-O-methyltransferase.

Authors:  Petteri Parkkila; Tapani Viitala
Journal:  ACS Chem Neurosci       Date:  2020-03-05       Impact factor: 4.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.